Statin Treatment Equalizes Long-Term Survival Between Patients With Single and Bilateral Internal Thoracic Artery Grafts

Annals of Thoracic Surgery

Volumn 88, Issue 3, 2009, Pages 789-795

  Carrier, Michel ^a   Cossette, Mariève ^a   Pellerin, Michel ^a   Hébert, Yves ^a   Bouchard, Denis ^a   Cartier, Raymond ^a   Demers, Philippe ^a   Jeanmart, Hugues ^a   Pagé, Pierre ^a   Perrault, Louis P ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTERY GRAFT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GROUPS BY AGE; HAZARD RATIO; HEALTH INSURANCE; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRESCRIPTION; PRIORITY JOURNAL; REOPERATION; SECONDARY PREVENTION; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 68849117668     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.04.097     Document Type: Article

References (22)

1. Loop F.D., Lytle B.W., Cosgrove D.M., et al. Influence of the internal mammary artery on 10-year survival and other cardiac events. N Engl J Med 314 (1986) 1-6
2. Lytle B.W., Blackstone E.H., Loop F.D., et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg 117 (1999) 855-872
3. Buxton B.F., Komeda M., Fuller J.A., and Gordon I. Bilateral internal thoracic artery grafting may improve outcome of coronary artery surgery. Risk-adjusted survival. Circulation 98 19 suppl (1998) II1-II6
4. Carrel T., Horber P., and Turina M.I. Operation for two-vessel coronary artery disease: midterm results of bilateral ITA grafting versus unilateral ITA and saphenous vein grafting. Ann Thorac Surg 62 (1996) 1289-1294
5. Cosgrove D.M., Lytle B.W., Loop F.D., et al. Does bilateral internal mammary artery grafting increase surgical risk?. J Thorac Cardiovasc Surg 95 (1988) 850-856
6. Dewar L.R., Jamieson W.R., Janusz M.T., et al. Unilateral versus bilateral internal mammary revascularization. Survival and event-free performance. Circulation 92 9 suppl (1995) II8-II13
7. Farinas J.M., Carrier M., Hebert Y., et al. Comparison of long-term clinical results of double versus single internal mammary artery bypass grafting. Ann Thorac Surg 67 (1999) 466-470
8. Fiore A.C., Naunheim K.S., Dean P., et al. Results of internal thoracic artery grafting over 15 years: single versus double grafts. Ann Thorac Surg 49 (1990) 202-208
9. Gansera B., Gunzinger R., and Angelis I. End of the millennium-end of the single thoracic artery graft?. Two thoracic arteries-standard for the next millennium? Early clinical results and analysis of risk factors in 1,487 patients with bilateral internal thoracic artery grafts. J Thorac Cardiovasc Surg 49 (2001) 10-15
10. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110 (2004) e340-e437
11. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 34 (1999) 1262-1347
12. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulant on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 336 (1997) 153-162
13. Goyal A., Alexander J.H., Hafley G.E., et al. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Ann Thorac Surg 83 (2007) 993-1001
14. Knatterud G.L., Rosenberg Y., Campeau L., et al. Long term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the Post Coronary Artery Bypass Graft Trial. Circulation 102 (2000) 157-165
15. Mangano D.T. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 (2002) 1309-1317
16. Ferguson Jr. T.B., Coombs L.P., and Peterson E.D. Preoperative β-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 287 (2002) 2221-2227
17. Rouleau J.L., Warnica W.J., Baillot R., et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 1 (2008) 24-31 117
18. Chello M., Anselmi A., Spadaccio C., et al. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg 83 (2007) 1374-1380
19. Chello M., Mastroroberto P., Patti G., D'ambrosio A., Di Sciascio, and Covino E. Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart 89 (2003) 538-543
20. Lazar H.L., Bao Y., Zhang Y., and Bernard S.A. Pretreatment with statins enhances myocardial protection during coronary revascularization. J Thorac Cardiovasc Surg 125 (2003) 1037-1042
21. Domanski M., Tian X., Fleg J., et al. Pleiotropic effect of lovastatin, with and without cholestyramine, in the Post Coronary Artery Bypass Graft (Post CABG) trial. Am J Cardiol 102 (2008) 1023-1027
22. Kulik A., Brookhart A., Levin R., Ruel M., Solomon D., and Choudhry N.K. Impact of statin use on outcomes after coronary artery bypass graft. Circulation 118 (2008) 1785-1792